|
| |
OctapharmaOctapharma, a Swiss-based company, is an independent, global plasma fractionation specialist. Its core business is the development, production and sale of high quality plasma derivatives.From its foundation in 1983 the company has grown to employ over 1482 people in 27 countries. Octapharma owns four modern, state-of-the-art production facilities in Austria, France, Sweden and Mexico. Since 2005 Octapharma also opperates the NSTOB plant in Springe Germany. Sales turnover in 2005 exceeded Euro 421 million
Recent Publications by Octapharma: |  |
Flow-based measurements of von Willebrand factor (VWF) function: Binding to collagen and platelet adhesion under physiological shear rate.
INTRODUCTION: VWF circulates in plasma as a series of heterogeneous... | 27th October, 2009
| Octapharma Research & Development, Molecular Biochemistry Department,
| Thromb Res. 2009 Oct 22.
DOI Direct Link |
Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Protein Therapeutics Association member companies.
BACKGROUND: Solvent/detergent (S/D) treatment is an established virus... | 24th September, 2009
| From the Biotest AG, Dreieich, Germany; Octapharma GmbH, Frankfurt,
| Transfusion. 2009 Sep;49(9):1931-43. Epub 2009 May 20.
DOI Direct Link |
Prion safety of transfusion plasma and plasma-derivatives typically used for prophylactic treatment.
Reports about transfusion-related transmissions of variant... | 25th July, 2009
| Octapharma Pharmazeutika Produktionsges.m.b.H, Pre-Clinical Research and
| Transfus Apher Sci. 2008 Aug;39(1):59-67. Epub 2008 Jul 10.
DOI Direct Link |
Prion removal effect of a specific affinity ligand introduced into the manufacturing process of the pharmaceutical quality solvent/detergent (S/D)-treated plasma OctaplasLG.
BACKGROUND AND OBJECTIVES: A new chromatographic step for the selective... | 25th June, 2009
| Research & Development, Octapharma Pharmazeutika Produktionsges.m.b.H,
| Vox Sang. 2009 Oct;97(3):226-33. Epub 2009 Jun 22.
DOI Direct Link |
Biochemical quality of the pharmaceutically licensed plasma OctaplasLG after implementation of a novel prion protein (PrPSc) removal technology and reduction of the solvent/detergent (S/D) process time.
BACKGROUND AND OBJECTIVES: A new chromatographic step for the selective... | 28th April, 2009
| Research and Development Department, Octapharma Pharmazeutika
| Vox Sang. 2009 Oct;97(3):219-25. Epub 2009 Apr 9.
DOI Direct Link |
→View more Octapharma research publications. |
Press Releases on Octapharma:
|
 |
| Octapharma Group and Fresenius Kabi Enter Into an Exclusive License, Development and Supply Agreement for a HESylated Recombinant Protein |
28th October, 2009 |
Octapharma |
BAD HOMBURG, Germany and LACHEN, Switzerland, Oct. 28 /PRNewswire/ -- Octapharma Group and Fresenius Kabi have signed a License, Development and Supply Agreement regarding the use of Fresenius Kabi
|
| Reportlinker Adds Immunotherapies and Vaccines for Nontraditional Indications |
26th October, 2009 |
Reportlinker |
NEW YORK, Oct. 26 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
Reportlinker Adds Immunotherapies and Vaccines for Nontraditional
|
| Octapharma AG Announces Second Quarter 2009 Results and Mid Term Outlook of the Market |
2nd October, 2009 |
Octapharma AG |
LACHEN, Switzerland, Oct. 2 /PRNewswire/ -- Through June 2009, Octapharma AG realized a record turnover of 536 M euro, compared to 422 M euro as of year-to-date June 2008, an increase of 27%.
(Photo:
|
| Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company Octapharma |
1st May, 2009 |
|
LACHEN, Switzerland, May 1 /PRNewswire/ -- The impending influenza pandemic will have implications for
global stocks of life-saving blood and blood products, warns Swiss-based
global biopharmaceutical
|
| Octapharma Agrees to Acquire 33 Plasma Centers Throughout the U.S. from International BioResources |
5th August, 2008 |
Octapharma |
LAFAYETTE, La. and LACHEN, Switzerland, Aug. 5 /PRNewswire/ -- Octapharma,
the largest privately owned plasma products company in the world, announced
today that it will acquire 33 plasma
|
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 12 individuals from Octapharma using this service.  Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 1745 times since April 2007, the link to the organisation's website has been followed 253 times Recent Search Terms used to find this page: octapharma pharmazeutika | life therapeutics octapharma | octapharma contact details | BAC signs licensing agreement with Octapharma | octapharma plasma sales | Octapharma patent | octapharma logo | octapharma plasma | octapharma plasma | octapharma | . This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Octapharma |
